Medpace Holdings, Inc. Files 8-K on Financials
Ticker: MEDP · Form: 8-K · Filed: Oct 21, 2024 · CIK: 1668397
| Field | Detail |
|---|---|
| Company | Medpace Holdings, Inc. (MEDP) |
| Form Type | 8-K |
| Filed Date | Oct 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: MEDP
TL;DR
MEDPACE filed an 8-K, check financials.
AI Summary
On October 21, 2024, Medpace Holdings, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing indicates Medpace Holdings, Inc. is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Medpace Holdings, Inc. (company) — Registrant
- 0001668397-24-000165 (other) — Accession Number
- October 21, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing by Medpace Holdings, Inc.?
The primary purpose of this 8-K filing is to report on Medpace Holdings, Inc.'s results of operations and financial condition, as well as to provide financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on October 21, 2024.
What is Medpace Holdings, Inc.'s principal executive office address?
Medpace Holdings, Inc.'s principal executive offices are located at 5375 Medpace Way, Cincinnati, Ohio 45227.
What is Medpace Holdings, Inc.'s IRS Employer Identification Number?
Medpace Holdings, Inc.'s IRS Employer Identification Number is 32-0434904.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 552 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-10-21 16:15:36
Key Financial Figures
- $0.01 — hange on which registered Common Stock $0.01 par value MEDP NASDAQ Global Select Mar
Filing Documents
- medp-20241021.htm (8-K) — 26KB
- medp-20241021exx991.htm (EX-99.1) — 173KB
- medpace-logoxonxwhite.jpg (GRAPHIC) — 10KB
- 0001668397-24-000165.txt ( ) — 350KB
- medp-20241021.xsd (EX-101.SCH) — 2KB
- medp-20241021_lab.xml (EX-101.LAB) — 21KB
- medp-20241021_pre.xml (EX-101.PRE) — 12KB
- medp-20241021_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On October 21, 2024, Medpace Holdings, Inc. (the "Company") issued a press release announcing its financial results for the three and nine months ended September 30, 2024. The full text of the press release was posted on the Company's internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated October 2 1 , 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MEDPACE HOLDINGS, INC. Date: October 21, 2024 By: /s/ Kevin M. Brady Kevin M. Brady, Chief Financial Officer